Antibiotic formulation for prevention of bacteria, fungi and mycoplasma contaminations in primary cell cultures.
Naïve Kupffer cells derived from human liver tissue. 0.5 million cells per vial.
Naïve Kupffer cells derived from human liver tissue. 0.2 million cells per vial
WinKQCLTM Software Version 6 Qualification Manual for Installation, Operation, and Performance, electronic delivery
WinKQCLTM Software Version 6 Qualification Manual for Installation, Operation, and Performance Qualification, Disc version
Cryopreserved ampule of Human Adipose-Derived Stem Cells (hADSC) containing ≥1 million cells
Human Liver-Derived Endothelial Cells
Note: Product will be discontinued follow depletion of current inventory. HLECP1 is the equivalent replacement.
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
-
Troubleshooting Guide - PYROGENT® Gel Clot LAL AssayMost problems encountered in the use of the PYROGENT® Gel Clot Limulus Amebocyte Lysate (LAL) Assay fall into two basic categories - no firm gels are observed in reaction tubes where firm gels are expected or firm gels form in reaction tubes, which are expected to yield negative results. This Tech Tip takes a deeper look into each of these categories and provides troubleshooting guidance.
-
Instructions - PYROGENT™ and PYROGENT™ Plus (Chinese)Detailed instructions for performing the PYROGENT™ and PYROGENT™ Plus Gel Clot LAL Assay
-
Instructions - PYROGENT® and PYROGENT® Plus (English)Detailed instructions for performing the PYROGENT® and PYROGENT® Plus Gel Clot LAL Assay
-
Troubleshooting Guide - Gel Clot LAL Assay Procedure (German)A step-by-step guide depicting how to perform a traditional gel clot LAL assay.
-
How To Perform The PYROGENT™ Gel Clot LAL AssayThe gel clot LAL assay is a qualitative test that provides simple positive-negative results. This video demonstrates how to perform the assay from start to finish.
-
Troubleshooting Guide - Testing Oil Solutions with PYROGENT® Gel Clot LAL AssayEndotoxins, due to their lipid character, tend to remain associated with oils and do not readily enter the aqueous phase of water-oil mixtures. This Tech Tip describes the use of a dispersing agent, PYROSPERSE®, to allow for dissociation of the endotoxin from the oils and for subsequent detection of endotoxin in the aqueous phase by the PYROGENT® Gel Clot LAL Assay.
-
Troubleshooting Guide - Gel Clot LAL Assay Procedure (English)A step-by-step guide depicting how to perform a traditional gel clot LAL assay.
-
Troubleshooting Guide - Gel Clot LAL Assay Procedure (French)A step-by-step guide depicting how to perform a traditional gel clot LAL assay.
-
Troubleshooting Guide - Gel Clot LAL Assay Procedure (Japanese)A step-by-step guide depicting how to perform a traditional gel clot LAL assay.
-
Troubleshooting Guide - Gel Clot LAL Assay Procedure (Portuguese)A step-by-step guide depicting how to perform a traditional gel clot LAL assay.